Effect of angiotensin II receptor blocker, valsartan, on insulin resistance of schizophrenic patients with olanzapine treatment

被引：0
|
作者：
Yamashita, Hakuei
Yoda, Hiroo
Saito, Masashi
Kuwabara, Michiko
Odagaki, Yuji
Kazawa, Tetsushi
Kikuchi, Atsuko
Maruki, Taeko
Toyoshima, Ryoichi
Kawazu, Shoji
机构：
[1] Moro Hosp, Dept Psychiat, Saitama, Japan
[2] Saitama Med Univ, Fac Med, Sch Med, Dept Neuropsychiat, Saitama, Japan
[3] Saitama Med Univ Hosp, Hlth Management Ctr, Saitama, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
O31
引用
收藏
页码：A9 / A10
页数：2
相关论文
共 50 条
  • [1] Angiotensin II type 1 receptor blocker, valsartan, ameliorates insulin resistance
    Shiuchi, T
    Cui, TX
    Wu, L
    Matsubara, Y
    Li, JM
    Ming, LJ
    Iwai, M
    Horiuchi, M
    JOURNAL OF HYPERTENSION, 2002, 20 : S60 - S61
  • [2] Effects of angiotensin II type-1 receptor blockers on insulin resistance in schizophrenic patients treated with olanzapine
    Yamashita, H.
    Minatogawa, Y.
    Kuroki, N.
    Yoda, H.
    Kazawa, T.
    Kawazu, S.
    Maruki, T.
    Toyoshima, R.
    Yamauchi, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 154 - 154
  • [3] Telmisartan, an angiotensin II type-1 receptor blocker, improved insulin resistance in a schizophrenic patient treated with olanzapine: A case report
    Yamashita, Hakuei
    Yoda, Hiroo
    Maruki, Taeko
    Toyoshima, Ryoichi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01): : 308 - 310
  • [4] Improvement of insulin resistance and microalbuminuria in patients with essential hypertension by angiotensin II receptor blocker
    Watanabe, S
    Okura, T
    Murakami, K
    Kurata, M
    Irita, J
    Manabe, S
    Miyoshi, K
    Fukuoka, T
    Higaki, J
    JOURNAL OF HYPERTENSION, 2005, 23 : S106 - S106
  • [5] Effect of valsartan, an angiotensin II receptor blocker, on postchallenge hyperglycemia and hyperinsulinemia in patients with coronary artery disease
    Koga, S.
    Ikeda, S.
    Yamasa, T.
    Yasunaga, T.
    Nakata, T.
    Kohno, S.
    Maemura, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 229 - 229
  • [6] An Efficient and Telescopic Process for Valsartan, an Angiotensin II Receptor Blocker
    Aalla, Sampath
    Gilla, Goverdhan
    Bojja, Yakambram
    Anumula, Raghupathi Reddy
    Vummenthala, Prabhakar Reddy
    Padi, Pratap Reddy
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (04) : 682 - 686
  • [7] Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan
    Clements, Richard T.
    Vang, Alexander
    Fernandez-Nicolas, Ana
    Kue, Nouaying R.
    Mancini, Thomas J.
    Morrison, Alan R.
    Mallem, Krishna
    McCullough, Danielle J.
    Choudhary, Gaurav
    CIRCULATION-HEART FAILURE, 2019, 12 (11)
  • [8] Insulin resistance and hyperuricemia in liver diseases: Incidence and improving effect by angiotensin II receptor blocker
    Enjoji, Munechika
    Kotoh, Kazuhiro
    Kato, Masaki
    Nakamuta, Makoto
    GASTROENTEROLOGY, 2007, 132 (04) : A815 - A815
  • [9] Angiotensin II infusion in prepuberty causes insulin resistance in adulthood by upregulation of cytokines, and an angiotensin II receptor blocker reverses insulin resistance
    Togashi, N.
    Yoshida, H.
    Miyazaki, Y.
    Maeda, T.
    Hyakukoku, M.
    Shimamoto, K.
    JOURNAL OF HYPERTENSION, 2008, 26 : S514 - S514
  • [10] Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD
    Suzuki, H
    Kanno, Y
    Sugahara, S
    Okada, H
    Nakamoto, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (06) : 1056 - 1064
12345